Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Feb 13, 2024 2:34pm
164 Views
Post# 35878144

Everyone ready????????

Everyone ready????????In the news today alone...alas....it IS a done deal.  I like the piece in the Boston Globe....lot of stock market money reading that today. 

1) Hundreds of pages of recently released documents provided by the Department of Health and Human Services (HHS) affirm what the overwhelming majority of the public has known for decades: 
 
Marijuana possesses therapeutic efficacy and its harms are not on par with those of heroin, or even alcohol.
 
Those were the explicit conclusions of the nation’s top federal health agency, along with the Food and Drug Administration and the National Institute on Drug Abuse, in a letter to the Drug Enforcement Administration (DEA) calling on the agency to remove “botanical cannabis” from its Schedule I prohibitive status in the federal Controlled Substances Act. 
 
2) From the Boston Globe....

Let’s stop treating pot like heroin
New federal study on its medical potential could lead the DEA to approve reclassification of the once ‘evil weed.’

3) Moving Marijuana To Schedule III Would Not Violate International Treaties, Legal Opinion Says

 

<< Previous
Bullboard Posts
Next >>